The Moderna Australia COVID-19 vaccine called Spikevax (elasomeran) has been provisionally approved by the TGA for people 18 and over.
It is recommended that the vaccine is given in two doses that are administered 28 days apart.
Data to support the use of Moderna’s COVID-19 vaccine in adolescents aged 12 to 17 years are currently under evaluation and no specific concerns have been identified to date. It is expected that the TGA’s decision on use in this age group will be announced in 3-4 weeks’ time.